CivaTech Oncology’s new device, CivaDerm™ has received FDA clearance. CivaDerm™ is a temporary radiation therapy product designed for intraoperative or surface radiation to treat skin cancer and other lesions.
CivaDerm™ radiation dosimetry plans have been compared to linac-based electron therapy plans. Multiple areas of the face and body were evaluated. Two comparison dose distributions for the nose and for the finger are shown in the figure below. “100% isodose line for [CivaDerm™] plans more closely correlated with the treatment depth than electron plans, and were more conformal to the curved surfaces.” Additionally, the skin surface dose was found to be acceptable for the CivaDerm™ plans.
CivaDerm™ with a 3mm bolus can “provide equivalent or better dose distribution than electron therapy.”
CIVADERM™ IS AN ALTERNATIVE TO ELECTRON
THERAPY FOR AREAS THAT ARE: